Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rhus verniciflua Stokes extract is a natural product derived from the lacquer tree, a medicinal plant traditionally used in East Asian countries such as Korea, Japan, and China. The extract is rich in bioactive flavonoids, including fustin, fisetin, sulfuretin, butein, and quercetin. To mitigate the risk of severe allergic reactions caused by urushiol, a toxin naturally present in the plant, an allergen-removed version (aRVS) has been developed for clinical use. This extract has been primarily investigated for its antineoplastic properties in various cancers, including advanced non-small cell lung cancer, pancreatic cancer, and gastric cancer, particularly within Korean integrative cancer centers. Its therapeutic effects are mediated through multiple pathways, including the induction of apoptosis via caspase-3 activation, inhibition of NF-κB and MAPK signaling, and suppression of matrix metalloproteinases (MMP-2 and MMP-9) involved in tumor invasion. Additionally, recent research has explored its potential in treating metabolic disorders such as obesity and metabolic dysfunction-associated steatotic liver disease (MASLD).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rhus verniciflua stokes extract.